These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3396268

  • 1. Serum antioxidant activity in diabetes mellitus.
    Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barnett AH.
    Diabetes Res; 1988 Feb; 7(2):89-92. PubMed ID: 3396268
    [Abstract] [Full Text] [Related]

  • 2. Primary plasma antioxidants in adult respiratory distress syndrome patients: changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins.
    Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW.
    J Lab Clin Med; 1994 Aug; 124(2):263-73. PubMed ID: 8051491
    [Abstract] [Full Text] [Related]

  • 3. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
    Van Campenhout A, Van Campenhout C, Lagrou AR, Abrams P, Moorkens G, Van Gaal L, Manuel-y-Keenoy B.
    Diabetes Metab Res Rev; 2006 Aug; 22(6):444-54. PubMed ID: 16506275
    [Abstract] [Full Text] [Related]

  • 4. Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes.
    Van Campenhout A, Van Campenhout C, Lagrou A, Manuel-y-Keenoy B.
    Biometals; 2008 Apr; 21(2):159-70. PubMed ID: 17585373
    [Abstract] [Full Text] [Related]

  • 5. Vitamin C metabolites and microangiopathy in diabetes mellitus.
    Jennings PE, Chirico S, Jones AF, Lunec J, Barnett AH.
    Diabetes Res; 1987 Nov; 6(3):151-4. PubMed ID: 3436115
    [Abstract] [Full Text] [Related]

  • 6. Serum antioxidant status in streptozotocin-induced diabetic rat.
    Asayama K, Nakane T, Uchida N, Hayashibe H, Dobashi K, Nakazawa S.
    Horm Metab Res; 1994 Jul; 26(7):313-5. PubMed ID: 7959605
    [Abstract] [Full Text] [Related]

  • 7. A novel method to quantify in vivo transferrin glycation: applications in diabetes mellitus.
    Van Campenhout A, Van Campenhout C, Olyslager YS, Van Damme O, Lagrou AR, Manuel-y-Keenoy B.
    Clin Chim Acta; 2006 Aug; 370(1-2):115-23. PubMed ID: 16513102
    [Abstract] [Full Text] [Related]

  • 8. Iron-binding antioxidant capacity is impaired in diabetes mellitus.
    Van Campenhout A, Van Campenhout C, Lagrou AR, Moorkens G, De Block C, Manuel-y-Keenoy B.
    Free Radic Biol Med; 2006 May 15; 40(10):1749-55. PubMed ID: 16678014
    [Abstract] [Full Text] [Related]

  • 9. Relationships between the copper and iron systems in hemodialysis patients and variables affecting these systems.
    Kirschbaum B.
    Biol Trace Elem Res; 2000 Oct 15; 77(1):13-24. PubMed ID: 11097467
    [Abstract] [Full Text] [Related]

  • 10. Serum, zinc, copper and insulin in diabetes mellitus.
    Mateo MC, Bustamante JB, Cantalapiedra MA.
    Biomedicine; 1978 Apr 15; 29(2):56-8. PubMed ID: 667289
    [Abstract] [Full Text] [Related]

  • 11. The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients.
    Roxborough HE, Mercer C, McMaster D, Maxwell AP, Young IS.
    Nephron; 2000 Mar 15; 84(3):211-7. PubMed ID: 10720890
    [Abstract] [Full Text] [Related]

  • 12. Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits.
    Duzguner V, Kaya S.
    Free Radic Biol Med; 2007 May 15; 42(10):1481-6. PubMed ID: 17448894
    [Abstract] [Full Text] [Related]

  • 13. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, Datz C.
    Gastroenterology; 2008 Aug 15; 135(2):680-8. PubMed ID: 18505688
    [Abstract] [Full Text] [Related]

  • 14. Role of plasma ascorbate in diabetic microangiopathy.
    Ali SM, Chakraborty SK.
    Bangladesh Med Res Counc Bull; 1989 Dec 15; 15(2):47-59. PubMed ID: 2629696
    [Abstract] [Full Text] [Related]

  • 15. [Serum levels of iron, copper, transferrin and ceruloplasmin oxidative activity in chronic circulatory failure].
    Bielak J.
    Pol Tyg Lek; 1971 Oct 15; 26(43):1654-7. PubMed ID: 5133680
    [No Abstract] [Full Text] [Related]

  • 16. Antioxidant enzymes show adaptation to oxidative stress in athletes and increased stress in hemodialysis patients.
    Knap B, Prezelj M, Buturović-Ponikvar J, Ponikvar R, Bren AF.
    Ther Apher Dial; 2009 Aug 15; 13(4):300-5. PubMed ID: 19695063
    [Abstract] [Full Text] [Related]

  • 17. Lipid peroxidation and antioxidant status in patients with diabetic retinopathy.
    Gupta MM, Chari S.
    Indian J Physiol Pharmacol; 2005 Apr 15; 49(2):187-92. PubMed ID: 16170987
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes.
    Lee DH, Zacharski LR, Jacobs DR.
    Am Heart J; 2006 Jun 15; 151(6):1247.e1-7. PubMed ID: 16781229
    [Abstract] [Full Text] [Related]

  • 19. Serum beta-glucuronidase activity in diabetic patients as related to vascular complications and degree of glucose metabolic disorder.
    Belfiore F, Lo Vecchio L, Napoli E.
    Am J Med Sci; 1972 Dec 15; 264(6):457-66. PubMed ID: 4631176
    [No Abstract] [Full Text] [Related]

  • 20. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E, Rossi L, Mariani S, Fagnani F, Quilici S, Cinapri V, Giampietro O.
    Nutr Metab Cardiovasc Dis; 2002 Aug 15; 12(4):184-9. PubMed ID: 12514938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.